Results 91 to 100 of about 13,799 (205)

Associations of Hearing Loss Defined by Updated World Health Organization Criteria With Socioeconomic Status and Health Check‐Up‐Related Factors: A Population‐Based Cross‐Sectional Study in Japan

Geriatrics &Gerontology International, Volume 26, Issue 8, August 2026.
Hearing loss (HL) was associated with lower socioeconomic status and several health check‐up–related factors, like lifestyle and examination data, especially among males. Among males, occupational noise exposure history, diabetes‐related factors, and excessive alcohol consumption showed stronger associations.
Yuri Akamatsu, Yasue Uchida, Mariko Shimono, Saiko Sugiura, Yukiko Nishita, Hiroshi Shimokata, Takeo Nakayama, Rei Otsuka   +7 more
wiley   +1 more source

Hesperidin activates Nrf2 to protect cochlear hair cells from cisplatin-induced damage

Redox Report
Cisplatin is widely employed in clinical oncology as an anticancer chemotherapy drug in clinical practice and is known for its severe ototoxic side effects.
Jintao Lou, Fan Wu, Wuhui He, Rui Hu, Ziyi Cai, Guisheng Chen, Wenji Zhao, Zhigang Zhang, Yu Si   +8 more
doaj   +1 more source

Selumetinib as a Target Therapy in Progressive Paediatric Low‐Grade Gliomas—Case Series (pLGG)

Journal of Paediatrics and Child Health, Volume 62, Issue 8, Page 1499-1508, August 2026.
ABSTRACT Background Optic pathway gliomas (OPGs) occur in 15%–20% of children with neurofibromatosis type 1 (NF1). While smaller gliomas may be only monitored, the current standard of care for symptomatic ones relies on chemotherapy, most commonly carboplatin and vincristine.
Laura Trapani, Giulia Gortani, Andrea Magnolato, Flora Maria Murru, Elisabetta Cattaruzzi, Laura Diplotti, Paola Michieletto, Silvia Giganti, Davide Zanon, Alessandra Maestro, Valentina Kiren, Egidio Barbi, Irene Bruno   +12 more
wiley   +1 more source

Nobiletin alleviates cisplatin-induced ototoxicity via activating autophagy and inhibiting NRF2/GPX4-mediated ferroptosis

Scientific Reports
Nobiletin, a citrus polymethoxy flavonoid with antiapoptotic and antioxidative properties, could safeguard against cisplatin-induced nephrotoxicity and neurotoxicity.
Wenao Song, Li Zhang, Xiaolin Cui, Rongrong Wang, Jingyu Ma, Yue Xu, Yan Jin, Dawei Wang, Zhiming Lu   +8 more
doaj   +1 more source

Cisplatin ototoxicity.

Practica Oto-Rhino-Laryngologica, 1985
Morita, Ichiro, Hosokawa, Satoru, Hiraide, Fumihisa, Inouye, Tetsuzo   +3 more
openaire   +2 more sources

Pharmacology and Ototoxicity

Seminars in Hearing, 2019
openaire   +3 more sources

Circadian-Related Serotonin/Melatonin Level Modulates Cisplatin Ototoxicity Susceptibility Depended on NOS3-NO Pathway. [PDF]

J Pineal Res
Qiu S, Cai S, Xie R, Liu C, He Y.
europepmc   +1 more source

Mechanisms, prevention, and management of aminoglycoside-induced hearing loss in neonates and children: a translational review. [PDF]

Front Pharmacol
Illamola SM, Sherwin CM, Ferguson LC, Birnbaum AK, Elluru RG, Vaughns JD.   +5 more
europepmc   +1 more source

Audiologic Assessment and Management of Teprotumumab-Associated Ototoxicity: An Updated Narrative Review. [PDF]

Audiol Res
Williams J, Elkins A, Sarigul A, Johnson MF, Bishop CE.   +4 more
europepmc   +1 more source

Ototoxicity Associated with Antineoplastic Agents in the Pediatric Population: An Evidence-Based Review of Auditory Monitoring Strategies and Contemporary Diagnostic Frameworks-Narrative Review. [PDF]

Diagnostics (Basel)
Wojno A, Cichy O, Wojno A, Dorobisz K, Pazdro-Zastawny K.   +4 more
europepmc   +1 more source